Follow the people · Insider
Leslie B. Daniels
Leslie B. Daniels files insider transactions with the SEC as a director of Anterix (ATEX). We hold 2 disclosed purchases and sales filed since 8 September 2008, 2 of them in the last 90 days.
- Files forATEX
- Disclosed buys and sells2 in all, 2 in the last 90 days
- Last disclosure8 September 2026
Positions held
4 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 2 September 2020 — 4 September 2026Director · Anterix (ATEX)19 Form 4 lines · source: SEC Form 4
- Filed 1 November 2021 — 22 May 2025Director · Redwire (RDW)17 Form 4 lines · source: SEC Form 4
- Filed 9 May 2018 — 3 March 2020Director · Gamco Investors, Inc. Et Al (GBL)3 Form 4 lines · source: SEC Form 4
- Filed 4 September 2008 — 16 August 2010Director · Bioanalytical Systems (BASI)2 Form 4 lines · source: SEC Form 4
Everything they disclosed
41 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 6,000 shares of AnterixSEC Form 48 September 2026Common Stock · traded 3 September 2026 · filed 8 September 2026
- ▼ sold on the open market 2,900 shares of AnterixSEC Form 48 September 2026Common Stock · traded 4 September 2026 · filed 8 September 2026
- ▼ sold on the open market 1,200 shares of AnterixSEC Form 48 September 2026Common Stock · traded 4 September 2026 · filed 8 September 2026
- was granted 1,598 shares of AnterixSEC Form 46 August 2026Common Stock · traded 4 August 2026 · filed 6 August 2026
- was granted 7,767 shares of AnterixSEC Form 47 August 2025Common Stock · traded 5 August 2025 · filed 7 August 2025
- was granted 11,802 shares of RedwireSEC Form 427 May 2025Common Stock, par value $0.0001 per share · traded 22 May 2025 · filed 27 May 2025
- was granted 5,002 shares of AnterixSEC Form 49 December 2024Common Stock · traded 5 December 2024 · filed 9 December 2024
- ▲ bought on the open market 2,000 shares of AnterixSEC Form 422 November 2024Common Stock · traded 20 November 2024 · filed 22 November 2024
- was granted 20,921 shares of RedwireSEC Form 428 May 2024Common Stock, par value $0.0001 per share · traded 23 May 2024 · filed 28 May 2024
- was granted 5,209 shares of AnterixSEC Form 430 August 2023Common Stock · traded 28 August 2023 · filed 30 August 2023
- was granted 41,153 shares of RedwireSEC Form 430 May 2023Common Stock, par value $0.0001 per share · traded 25 May 2023 · filed 30 May 2023
- ▲ bought on the open market 3,938 shares of RedwireSEC Form 416 December 2022Common Stock, par value $0.0001 per share · traded 14 December 2022 · filed 16 December 2022
- ▲ bought on the open market 7,000 shares of RedwireSEC Form 413 December 2022Common Stock, par value $0.0001 per share · traded 12 December 2022 · filed 13 December 2022
- ▲ bought on the open market 1,500 shares of RedwireSEC Form 413 December 2022Common Stock, par value $0.0001 per share · traded 12 December 2022 · filed 13 December 2022
- ▲ bought on the open market 1,500 shares of RedwireSEC Form 413 December 2022Common Stock, par value $0.0001 per share · traded 12 December 2022 · filed 13 December 2022
- ▲ bought on the open market 5,000 shares of RedwireSEC Form 413 December 2022Common Stock, par value $0.0001 per share · traded 12 December 2022 · filed 13 December 2022
- ▲ bought on the open market 2,000 shares of RedwireSEC Form 49 December 2022Common Stock, par value $0.0001 per share · traded 7 December 2022 · filed 9 December 2022
- ▲ bought on the open market 4,497 shares of RedwireSEC Form 49 December 2022Common Stock, par value $0.0001 per share · traded 7 December 2022 · filed 9 December 2022
- ▲ bought on the open market 15,000 shares of RedwireSEC Form 416 November 2022Common Stock, par value $0.0001 per share · traded 14 November 2022 · filed 16 November 2022
- was granted 3,595 shares of AnterixSEC Form 422 August 2022Common Stock · traded 10 August 2022 · filed 22 August 2022
- was granted 32,895 shares of RedwireSEC Form 431 May 2022Common Stock, par value $0.0001 per share · traded 26 May 2022 · filed 31 May 2022
- ▲ bought on the open market 5,000 shares of RedwireSEC Form 424 May 2022Common Stock, par value $0.0001 per share · traded 20 May 2022 · filed 24 May 2022
- ▲ bought on the open market 10,000 shares of RedwireSEC Form 420 May 2022Common Stock, par value $0.0001 per share · traded 18 May 2022 · filed 20 May 2022
- ▲ bought on the open market 10,000 shares of RedwireSEC Form 420 May 2022Common Stock, par value $0.0001 per share · traded 19 May 2022 · filed 20 May 2022
- ▲ bought on the open market 10,000 shares of RedwireSEC Form 420 May 2022Common Stock, par value $0.0001 per share · traded 19 May 2022 · filed 20 May 2022
- was granted 12,500 shares of RedwireSEC Form 43 January 2022Common Stock, par value $0.0001 per share · traded 1 November 2021 · filed 3 January 2022
- ▲ bought on the open market 1,000 shares of AnterixSEC Form 419 August 2021Common Stock · traded 18 August 2021 · filed 19 August 2021
- was granted 2,834 shares of AnterixSEC Form 410 August 2021Common Stock · traded 6 August 2021 · filed 10 August 2021
- ▲ bought on the open market 1,000 shares of AnterixSEC Form 422 June 2021Common Stock · traded 18 November 2020 · filed 22 June 2021
- ▲ bought on the open market 1,000 shares of AnterixSEC Form 422 June 2021Common Stock · traded 18 November 2020 · filed 22 June 2021
- ▲ bought on the open market 4,000 shares of AnterixSEC Form 48 March 2021Common Stock · traded 5 March 2021 · filed 8 March 2021
- ▲ bought on the open market 2,000 shares of AnterixSEC Form 41 March 2021Common Stock · traded 25 February 2021 · filed 1 March 2021
- ▲ bought on the open market 2,000 shares of AnterixSEC Form 41 March 2021Common Stock · traded 26 February 2021 · filed 1 March 2021
- ▲ bought on the open market 3,000 shares of AnterixSEC Form 424 February 2021Common Stock · traded 22 February 2021 · filed 24 February 2021
- ▲ bought on the open market 2,000 shares of AnterixSEC Form 424 November 2020Common Stock · traded 23 November 2020 · filed 24 November 2020
- was granted 2,072 shares of AnterixSEC Form 43 September 2020Common Stock · traded 2 September 2020 · filed 3 September 2020
- ▲ bought on the open market 6,637 shares of Gamco Investors, Inc. Et AlSEC Form 43 March 2020Class A Common Stock · traded 2 March 2020 · filed 3 March 2020
- ▲ bought on the open market 3,363 shares of Gamco Investors, Inc. Et AlSEC Form 43 March 2020Class A Common Stock · traded 3 March 2020 · filed 3 March 2020
- was granted 10,000 shares of Gamco Investors, Inc. Et Al (a derivative holding)SEC Form 410 May 2018Director Stock Option (Right to Buy) · traded 9 May 2018 · filed 10 May 2018
- was granted 5,000 shares of Bioanalytical Systems (a derivative holding)SEC Form 418 August 2010Option to purchase common shares · traded 16 August 2010 · filed 18 August 2010
- had shares withheld for tax on 10,000 shares of Bioanalytical Systems (a derivative holding)SEC Form 48 September 2008Employee Stock Option (Right to Buy) · traded 4 September 2008 · filed 8 September 2008
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.